GO:0032367 intracellular cholesterol transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032367 (intracellular cholesterol transport) describes the directed movement of cholesterol within cells, a process essential for membrane homeostasis, steroidogenesis, and lipid signaling.
• Cholesterol moves between organelles via vesicular and non-vesicular pathways, often at membrane contact sites, and is mediated by proteins such as NPC1, NPC2, OSBP, and ORP family members.
• Defects in intracellular cholesterol transport are linked to lysosomal storage disorders (e.g., Niemann-Pick type C), cardiovascular disease, and metabolic syndromes.
• Key experimental approaches include fluorescent cholesterol analogs, live-cell imaging, subcellular fractionation, and genetic screens using CRISPR knockout libraries.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of gene function in cholesterol trafficking pathways.
• Understanding this process offers therapeutic targets for dyslipidemias, neurodegeneration, and cancer, where cholesterol trafficking is often reprogrammed.
Description
Intracellular cholesterol transport (GO:0032367) is the directed movement of cholesterol, cholest-5-en-3-beta-ol, within cells. Cholesterol is a vital component of cellular membranes and a precursor for steroid hormones, bile acids, and vitamin D, but its accumulation in wrong compartments is toxic. Therefore, cells have evolved elaborate transport mechanisms to distribute cholesterol among organelles such as the endoplasmic reticulum (ER), plasma membrane, endosomes, lysosomes, and mitochondria. This process is fundamental to membrane integrity, signal transduction, and lipid metabolism. Research into intracellular cholesterol transport has accelerated with the discovery of membrane contact sites and lipid transfer proteins that shuttle cholesterol non-vesicularly. Dysregulation of this transport is implicated in diseases ranging from Niemann-Pick type C to atherosclerosis and cancer. Consequently, tools to manipulate and monitor cholesterol movement are in high demand. This article provides a comprehensive overview of GO:0032367, covering its definition, molecular players, regulatory mechanisms, disease relevance, and state-of-the-art research methods, including CRISPR-based models. All facts are drawn from peer-reviewed literature to support researchers and AI-driven knowledge retrieval [1-8].
intracellular cholesterol transport At A Glance
| GO ID | GO:0032367 |
|---|---|
| GO term | intracellular cholesterol transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of cholesterol within cells, ensuring proper distribution among organelles for membrane homeostasis, steroidogenesis, and signaling. |
| Key cellular locations | Endoplasmic reticulum, plasma membrane, endosomes, lysosomes, mitochondria, peroxisomes, Golgi apparatus. |
| Major protein families | NPC1/NPC2, OSBP/ORPs, ABC transporters, StAR family, MLN64, and others. |
| Associated diseases | Niemann-Pick type C, atherosclerosis, metabolic syndrome, neurodegeneration, cancer. |
| Research methods | Fluorescent cholesterol analogs, live-cell imaging, subcellular fractionation, CRISPR screens, lipidomics. |
What Is GO:0032367?
According to the Gene Ontology, GO:0032367 (intracellular cholesterol transport) is defined as the directed movement of cholesterol, cholest-5-en-3-beta-ol, within cells. This encompasses all processes that mediate the translocation of cholesterol between cellular compartments, including vesicular trafficking and non-vesicular transfer at membrane contact sites. It does not include cholesterol uptake from outside the cell or cholesterol biosynthesis, but rather the internal distribution and redistribution of cholesterol molecules.
Why Is intracellular cholesterol transport Important in Cell Biology?
Intracellular cholesterol transport is crucial for maintaining cellular cholesterol homeostasis, which is essential for normal cell function and survival. Disruption of this process leads to cholesterol accumulation in inappropriate organelles, triggering cellular stress, inflammation, and death. Moreover, cholesterol trafficking influences membrane fluidity, signal transduction, and the production of steroid hormones and bile acids. Understanding the molecular mechanisms of GO:0032367 is therefore vital for developing therapies for a wide range of diseases, including lysosomal storage disorders, cardiovascular disease, and cancer.
• Maintains cholesterol homeostasis by distributing cholesterol among organelles.
• Supports membrane biogenesis and integrity.
• Enables steroid hormone synthesis in mitochondria.
• Facilitates bile acid production in the liver.
• Regulates cell signaling by modulating membrane lipid composition.
• Prevents cholesterol toxicity in lysosomes and other organelles.
• Implicated in Niemann-Pick type C disease and other lysosomal storage disorders.
• Contributes to atherosclerosis and cardiovascular disease.
• Plays a role in cancer cell proliferation and survival.
• Provides targets for therapeutic intervention in metabolic diseases.
What Happens During intracellular cholesterol transport?
Cholesterol Uptake and Delivery to Lysosomes
In simple terms: Cells take up cholesterol from outside and send it to lysosomes for processing.
Cholesterol enters cells primarily via receptor-mediated endocytosis of low-density lipoprotein (LDL). LDL is delivered to lysosomes, where acid lipases hydrolyze cholesteryl esters to free cholesterol. This free cholesterol must then be exported from lysosomes to other organelles, a step requiring the coordinated action of NPC1 and NPC2 proteins. Defects in this step cause cholesterol accumulation in lysosomes, as seen in Niemann-Pick type C disease.
Vesicular Transport from Lysosomes to Plasma Membrane and ER
In simple terms: Cholesterol moves in small vesicles from lysosomes to other parts of the cell.
After export from lysosomes, cholesterol can be transported to the plasma membrane and the endoplasmic reticulum (ER) via vesicular trafficking. This involves Rab GTPases and other regulators that control vesicle formation and fusion. The ER senses cholesterol levels and regulates synthesis and uptake through SREBP and HMG-CoA reductase. Proper vesicular transport is essential for maintaining cholesterol balance and preventing accumulation in late endosomes/lysosomes.
Non-vesicular Transport at Membrane Contact Sites
In simple terms: Cholesterol can also hop directly between organelles at points where they touch.
Membrane contact sites (MCSs) are regions where two organelles are closely apposed, allowing direct transfer of lipids including cholesterol. Proteins such as OSBP and ORP family members mediate non-vesicular cholesterol transport at ER-mitochondria, ER-plasma membrane, and ER-endosome contacts. This pathway is rapid and energy-independent, and it is critical for cholesterol distribution and signaling. Recent studies have highlighted the role of MCSs in cholesterol trafficking and their implication in disease.
Mitochondrial Cholesterol Transport for Steroidogenesis
In simple terms: Cholesterol is moved into mitochondria to make hormones like cortisol and testosterone.
In steroidogenic tissues, cholesterol is transported from the outer to the inner mitochondrial membrane by the StAR protein and other factors. This step is rate-limiting for steroid hormone synthesis. Cholesterol is then converted to pregnenolone by CYP11A1 in the inner membrane. Disruption of mitochondrial cholesterol transport leads to steroidogenic defects and disease.
Regulation of Intracellular Cholesterol Transport
In simple terms: Cells adjust cholesterol movement based on their needs and external signals.
Intracellular cholesterol transport is regulated by cholesterol levels themselves, hormones, and nutrient sensors such as mTOR. For example, mTOR inhibition reprograms lipid homeostasis and promotes cholesterol transport to the plasma membrane. Additionally, oxysterols and bile acids can modulate transport and recycling of transporters like NPC1L1. These regulatory mechanisms ensure that cholesterol is delivered to the right place at the right time.
Key Genes Involved in GO:0032367 intracellular cholesterol transport
The following genes encode proteins with established roles in intracellular cholesterol transport (GO:0032367) and are commonly studied in this context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NPC1 | Mediates cholesterol export from lysosomes | Mutations cause Niemann-Pick type C; target for lysosomal storage disease research. |
| NPC2 | Binds cholesterol in lysosomes and transfers to NPC1 | Defects lead to Niemann-Pick type C; studied for cholesterol trafficking mechanisms. |
| OSBP | Non-vesicular cholesterol transfer at ER-Golgi contact sites | Regulates cholesterol distribution and signaling; implicated in cancer and metabolic disease. |
| ORP1L | Cholesterol transfer at ER-endosome contacts | Involved in endosomal cholesterol trafficking and autophagy. |
| STAR | Transfers cholesterol into mitochondria for steroidogenesis | Mutations cause lipoid congenital adrenal hyperplasia; key for hormone synthesis. |
| CYP11A1 | Converts cholesterol to pregnenolone in mitochondria | Essential for steroid hormone production; studied in endocrine disorders. |
| ABCA1 | Mediates cholesterol efflux to apoA-I | Defects cause Tangier disease; important for HDL metabolism. |
| ABCG1 | Promotes cholesterol efflux to HDL | Linked to cardiovascular disease and macrophage foam cell formation. |
| SCARB1 | HDL receptor mediating selective cholesterol uptake | Regulates plasma cholesterol levels; target for atherosclerosis research. |
| LDLR | Binds and internalizes LDL | Mutations cause familial hypercholesterolemia; central to cholesterol uptake. |
| SOAT1 | Converts cholesterol to cholesteryl esters for storage | Regulates free cholesterol levels; studied in atherosclerosis and cancer. |
| SREBF2 | Transcription factor controlling cholesterol synthesis and uptake | Master regulator of cholesterol homeostasis; target for dyslipidemia. |
| HMGCR | Rate-limiting enzyme in cholesterol synthesis | Target of statins; feedback regulated by cholesterol transport. |
| NR1H2 | Liver X receptor beta, regulates cholesterol efflux and transport | Implicated in lipid metabolism and inflammation. |
| NR1H3 | Liver X receptor alpha, controls cholesterol homeostasis | Therapeutic target for atherosclerosis and metabolic disease. |
| MLN64 | Transfers cholesterol from endosomes to mitochondria | Involved in steroidogenesis and cholesterol trafficking. |
| VPS35 | Retromer component, regulates endosomal cholesterol transport | Linked to Parkinson's disease and cholesterol dysregulation. |
How Is intracellular cholesterol transport Regulated?
Intracellular cholesterol transport is regulated at multiple levels to maintain cellular cholesterol homeostasis. The mTOR pathway plays a key role; inhibition of mTOR reprograms lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport to the plasma membrane. Bile acids can also modulate intracellular cholesterol transport by promoting NPC1L1 recycling, thereby enhancing intestinal cholesterol absorption. Additionally, oxysterols and nuclear receptors such as LXRs regulate the expression of genes involved in cholesterol efflux and transport. Membrane contact sites are dynamically regulated by calcium and lipid signals, allowing rapid adaptation to cellular needs. These regulatory mechanisms ensure that cholesterol is distributed appropriately and prevent toxic accumulation.
intracellular cholesterol transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPC1 | Niemann-Pick type C | NPC1 knockout HeLa or iPSC-derived neurons; point mutations for NPC1 variants. |
| ABCA1 | Tangier disease, atherosclerosis | ABCA1 knockout macrophages; overexpression for efflux studies. |
| LDLR | Familial hypercholesterolemia | LDLR knockout HepG2 cells; knock-in of patient mutations. |
| STAR | Lipoid congenital adrenal hyperplasia | STAR knockout adrenal cells; overexpression for steroidogenesis. |
| VPS35 | Parkinson's disease | VPS35 knockout neurons; point mutation knock-in for PD variants. |
Niemann-Pick Type C Disease
Niemann-Pick type C (NPC) is a lysosomal storage disorder caused by mutations in NPC1 or NPC2, leading to defective cholesterol export from lysosomes. This results in cholesterol accumulation in late endosomes/lysosomes, causing neurodegeneration, hepatosplenomegaly, and early death. Research on intracellular cholesterol transport has been instrumental in understanding NPC pathogenesis and developing potential therapies.
Cardiovascular Disease and Atherosclerosis
Dysregulated intracellular cholesterol transport contributes to atherosclerosis by promoting foam cell formation and plaque development. Impaired cholesterol efflux from macrophages, mediated by ABCA1 and ABCG1, leads to cholesterol accumulation and inflammation. Genetic variants in genes such as SCARB1 and LDLR affect plasma cholesterol levels and cardiovascular risk. Targeting cholesterol transport pathways is a promising strategy for treating dyslipidemias.
Cancer and Metabolic Reprogramming
Cancer cells often reprogram cholesterol metabolism to support rapid proliferation. Intracellular cholesterol transport is altered in many cancers, contributing to membrane biogenesis and signaling. For example, mTOR inhibition induces cholesterol transport and lipid uptake, which may affect cancer cell survival. Understanding these pathways could reveal new therapeutic targets.
Neurodegenerative Disorders
Cholesterol transport defects are increasingly linked to neurodegenerative diseases such as Alzheimer's and Parkinson's. The retromer component VPS35, involved in endosomal cholesterol transport, is associated with Parkinson's disease. Disrupted cholesterol trafficking in neurons can lead to synaptic dysfunction and cell death. Thus, GO:0032367 is relevant to neurodegeneration research.
From intracellular cholesterol transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of NPC1 in lysosomal cholesterol export? | NPC1 knockout cell lines (e.g., HeLa, fibroblasts). |
| How do point mutations in NPC1 affect cholesterol transport? | CRISPR point mutation knock-in of NPC1 variants. |
| Does overexpression of OSBP enhance non-vesicular cholesterol transport? | OSBP overexpression in HEK293 cells. |
| What is the effect of STAR knockout on steroidogenesis? | STAR knockout in adrenal cell lines (e.g., H295R). |
| Can we visualize cholesterol transport in live cells? | Tagged knock-in of cholesterol-binding proteins (e.g., mCherry-NPC1). |
| What genes regulate cholesterol transport under mTOR inhibition? | CRISPR library screening in cells treated with mTOR inhibitors. |
How to Study the intracellular cholesterol transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| BODIPY-cholesterol imaging | Real-time cholesterol distribution and transport | Live-cell imaging of lysosome-to-PM transport. |
| Filipin staining | Free cholesterol accumulation in cells | Diagnosis of Niemann-Pick type C. |
| Subcellular fractionation + lipidomics | Cholesterol content in isolated organelles | Quantifying transport defects. |
| CRISPR knockout screen | Genes affecting cholesterol transport | Identifying regulators under mTOR inhibition. |
| Proximity labeling (BioID) | Protein interactors at membrane contact sites | Mapping OSBP/ORP interactomes. |
| RNA-seq | Transcriptional changes in cholesterol transport genes | Response to cholesterol loading or mTOR inhibition. |
| Immunofluorescence | Localization of cholesterol transport proteins | Studying NPC1 and NPC2 trafficking. |
| Steroid hormone assays | Production of steroids from cholesterol | Assessing STAR and CYP11A1 function. |
Fluorescent Cholesterol Analogs and Live-Cell Imaging
Fluorescent cholesterol analogs such as BODIPY-cholesterol or Filipin are used to visualize cholesterol distribution and transport in live cells. Live-cell imaging with these probes allows real-time tracking of cholesterol movement between organelles. This method is essential for studying dynamic transport processes and the effects of genetic perturbations.
Subcellular Fractionation and Lipidomics
Subcellular fractionation followed by lipidomics enables quantification of cholesterol in isolated organelles. This approach provides a snapshot of cholesterol distribution and can reveal transport defects. Mass spectrometry-based lipidomics offers high sensitivity and specificity for cholesterol and its metabolites.
CRISPR Screens for Cholesterol Transport Regulators
Genome-wide CRISPR knockout or activation screens can identify genes that regulate intracellular cholesterol transport. For example, a screen under mTOR inhibition revealed alternative lipid uptake and cholesterol transport pathways. These screens are powerful for discovering novel players and therapeutic targets.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry can identify protein complexes involved in cholesterol transport. Proximity labeling techniques such as BioID can map membrane contact site proteins. These methods help elucidate the molecular machinery of cholesterol trafficking.
How CRISPR Can Be Used to Study GO:0032367 intracellular cholesterol transport
Knockout
CRISPR knockout (KO) of genes such as NPC1, NPC2, or OSBP provides definitive loss-of-function models to study intracellular cholesterol transport. KO cell lines can be used to measure cholesterol accumulation, transport kinetics, and downstream effects on signaling. For example, NPC1 KO cells recapitulate the cholesterol storage phenotype of Niemann-Pick type C.
Point Mutation
CRISPR point mutation knock-in allows introduction of specific disease-associated mutations, such as those in NPC1 or LDLR, to study their impact on cholesterol transport. This approach preserves endogenous expression levels and regulatory context, offering more physiological relevance than overexpression. Point mutation models are valuable for testing allele-specific therapies.
Knock-in
Knock-in of tagged versions of cholesterol transport proteins (e.g., GFP-NPC1) enables live-cell imaging and proteomic studies. Tagged knock-in models avoid artifacts from overexpression and allow visualization of endogenous protein dynamics. They are also useful for isolating protein complexes from native cells.
Overexpression
Overexpression of genes like OSBP or STARD3 can enhance specific cholesterol transport pathways and reveal their sufficiency in driving transport. Overexpression models are useful for gain-of-function studies and for producing sufficient material for biochemical assays. However, careful controls are needed to avoid artifacts from supraphysiological expression.
How EDITGENE Supports intracellular cholesterol transport Research
Researchers studying intracellular cholesterol transport-related genes often need to determine whether a candidate gene is causally involved in cholesterol trafficking, and to dissect its precise function using well-controlled genetic models. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for intracellular cholesterol transport research.
Frequently Asked Questions About intracellular cholesterol transport
What is intracellular cholesterol transport?
Intracellular cholesterol transport (GO:0032367) is the directed movement of cholesterol within cells, involving vesicular and non-vesicular pathways that distribute cholesterol among organelles.
What genes are involved in intracellular cholesterol transport?
Key genes include NPC1, NPC2, OSBP, ORP1L, STAR, ABCA1, ABCG1, LDLR, and SREBF2, among others.
What is the role of NPC1 in cholesterol transport?
NPC1 mediates the export of cholesterol from lysosomes to other cellular compartments; mutations cause Niemann-Pick type C disease.
How is cholesterol transported within cells?
Cholesterol moves via vesicular trafficking and non-vesicular transfer at membrane contact sites, mediated by lipid transfer proteins like OSBP and ORPs.
What diseases are associated with defective intracellular cholesterol transport?
Diseases include Niemann-Pick type C, atherosclerosis, Tangier disease, and neurodegenerative disorders like Parkinson's.
What methods are used to study intracellular cholesterol transport?
Common methods include fluorescent cholesterol analogs, live-cell imaging, subcellular fractionation, lipidomics, and CRISPR screens.
How does mTOR regulate cholesterol transport?
mTOR inhibition reprograms lipid homeostasis and promotes cholesterol transport to the plasma membrane, partly by inducing alternative lipid uptake.
What are membrane contact sites in cholesterol transport?
Membrane contact sites are regions where organelles are closely apposed, allowing direct cholesterol transfer by proteins such as OSBP and ORP1L.
Can CRISPR be used to study cholesterol transport?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in cholesterol transport.
What is the QuickGO definition of GO:0032367?
The QuickGO definition is: The directed movement of cholesterol, cholest-5-en-3-beta-ol, within cells.
Conclusion
Intracellular cholesterol transport (GO:0032367) is a fundamental cellular process that ensures proper cholesterol distribution and homeostasis. Its dysregulation underlies a spectrum of diseases, from lysosomal storage disorders to cardiovascular disease and cancer. Advances in imaging, lipidomics, and CRISPR-based genetic models continue to unravel the molecular mechanisms and regulatory networks involved. Targeting these pathways holds promise for novel therapeutic interventions.
References
- 1. Soccio RE et al.. 2004. Intracellular cholesterol transport.. Arterioscler Thromb Vasc Biol 24(7):1150-60 PMID: 15130918
- 2. Ikonen E et al.. 2023. Intracellular Cholesterol Trafficking.. Cold Spring Harb Perspect Biol 15(8) PMID: 37277190
- 3. Fielding CJ et al.. 1997. Intracellular cholesterol transport.. J Lipid Res 38(8):1503-21 PMID: 9300773
- 4. Liscum L et al.. 1992. Intracellular cholesterol transport.. J Lipid Res 33(9):1239-54 PMID: 1402394
- 5. Chu BB et al.. 2015. Cholesterol transport through lysosome-peroxisome membrane contacts.. Cell 161(2):291-306 PMID: 25860611
- 6. Xiao J et al.. 2023. Bile acids-mediated intracellular cholesterol transport promotes intestinal cholesterol absorption and NPC1L1 recycling.. Nat Commun 14(1):6469 PMID: 37833289
- 7. Shin S et al.. 2025. mTOR inhibition reprograms cellular lipid homeostasis by inducing alternative lipid uptake and promoting cholesterol transport.. Mol Cell 85(18):3486-3504.e7 PMID: 40972529
- 8. Du X et al.. 2015. Novel mechanisms of intracellular cholesterol transport: oxysterol-binding proteins and membrane contact sites.. Curr Opin Cell Biol 35:37-42 PMID: 25932595
